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In previous issue of Hepatitis Monthly, La Torre G et al. 
from Sapienza University and the Catholic University of 
the Sacred Heart located in Rome, Italy, have published 
their findings on the incidence of hepatitis C virus (HCV) 
infections in Italy (1). In the Italian general population, 
they estimate that the overall trend, and also the trends 
in gender and different age groups, has decreased sig-
nificantly over the period from 1996 to 2006, with an 
overall significant decrease in incidence from 2.02 to 
0.55 per 100,000. The incidence rates were estimated us-
ing the data from the system for acute viral hepatitis in 
Italy (SEIEVA) and population data from ISTAT. A marked 
decrease in incidence was observed in all age groups. A 
similar rate of decrease was observed in the 25–64-year-
old and the greater than 65-year-old age groups. A more 
pronounced decrease was observed in the 15–24-year-old 
age group, whereas a low decrease was observed in the 
0–14-year-old age group, primarily because of the existing 
low incidence in 1996 (1). In the male population, which 
had a significantly higher incidence rate than the female 
population in 1996, the decrease was more marked with 
a clear trend of diminishing gender differences in HCV 
incidence in 2006, and with a lower (but probably not 
significant) incidence rate in males aged 0–14 years (0.05 
vs. 0.15/100,000). The estimated decrease in the overall 
annual incidence was -12.5%. This study shows an encour-
aging favorable trend toward a low incidence of HCV in 
Italy, and it confirms previous findings in this country 
(2, 3). The trend described in this study is similar to the 
trends observed in Canada (4), Western Europe (4), and 
the  USA  (5-7);  however,  contrary  trends  have  been  ob-
served in Eastern Europe and Russia (4), and also among 
adolescents and young adults in some states of the USA 
(8-10) and in US population groups (11). Estimation of the 
incidence of HCV infection remains difficult; reporting 
systems can underestimate the incidence of HCV infec-
tion despite well-established surveillance systems, such 
as that in Italy. Regular population-based surveys should 
be conducted to confirm these findings. 
The notable decrease in the incidence rate seen in the 
last 2 decades in Italy is mainly attributed to the improve-
ment in the safety of blood supplies and blood products, 
use of safe injection practices, and implementation of 
universal precautions in medical settings. Intravenous 
drug  use,  other  parenteral  exposure  i.e.  ear  piercing, 
tattooing), surgery, hospitalization, and dental treat-
ment remain common risk factors among patients with 
HCV infection, particularly in resource-limited settings. 
Therefore, there is still no room for complacency. The 
public health agenda warrants maintaining surveillance, 
prevention, and control of HCV infection. The joint-point 
regression method used in this study may help to assess 
the impact of public health policies to meet the chal-
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lenges posed by HCV infection and disease and to foster 
new public health strategies. However, it must be kept in 
mind that infectious disease epidemics rarely follow lin-




1.  La Torre G, Gualano MR, Semyonov L, Nicolotti N, Ricciardi W, 
Boccia A. Hepatitis C Virus Infection Trends in Italy, 1996-2006. 
Hepat Mon. 2011;11(11):895-900.
2.  Spada E, Mele A, Ciccozzi M, Tosti ME, Bianco E, Szklo A, et al. 
Changing epidemiology of parenterally transmitted viral hepa-
titis: results from the hepatitis surveillance system in Italy. Dig 
Liver Dis. 2001;33(9):778-84.
3.  Zanetti AR, Romano L. Evolving epidemiology of viral hepatitis 
in Italy. Dig Liver Dis. 2001;33(9):740-2.
4.  Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper 
C, et al. A systematic review of hepatitis C virus epidemiology in 
Europe, Canada and Israel. Liver Int. 2011;31(2):30-60.
5.  Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997;26(3 Sup-
pl 1):62-5.
6.  Williams IT, Bell BP, Kuhnert W, Alter MJ. Incidence and trans-
mission patterns of acute hepatitis C in the United States, 1982-
2006. Arch Int Med. 2011;171(3):242-8.
7.  Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vla-
hov D, et al. Changes in blood-borne infection risk among injec-
tion drug users. J Infec Dis. 2011;203(5):587-94.
8.  Hepatitis C virus infection among adolescents and young 
adults:Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 
2011;60(17):537-41.
9.  Use of enhanced surveillance for hepatitis C virus infection 
to  detect  a  cluster  among  young  injection-drug  users--new 
York, November 2004-April 2007. MMWR Morb Mortal Wkly Rep. 
2008;57(19):517-21.
10.  Church D, Barton K, Elson F, DeMaria A, Cranston K, Harris N, et 
al. Risk Factors for Hepatitis C Virus Infections Among Young 
Adults  —  Massachusetts,  2010.  MMWR Morb Mortal Wkly Rep. 
2011;60(42):1457-8.
11.  Salihu HM, Connell L, Salemi JL, August EM, Weldeselasse HE, 
Alio AP. Prevalence and Temporal Trends of Hepatitis B, Hepatitis 
C, and HIV/AIDS Co-infection During Pregnancy Across the De-
cade, 1998-2007. J Women’s Health. 2011:[Epub ahead of print].